NCT01991535

Brief Summary

The purpose of this study is to determine whether breathing pattern (specifically the inspiratory time/total respiratory cycle value) has an influence over the response to the noninvasive mechanical ventilation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 18, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 25, 2013

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Last Updated

March 21, 2024

Status Verified

October 1, 2015

First QC Date

November 18, 2013

Last Update Submit

March 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Transcutaneous carbon dioxide measurement

    One hour

Secondary Outcomes (1)

  • Inspiratory-time/total-respiratory-cycle value

    One hour

Interventions

Respiratory rate and duration of inspiration are controlled by the patient. Device model: Stellar 150® (ResMed, Australia).

Ventilator maintains the positive end-expiratory pressure until the patient inspires. At that point, the ventilator reaches the support pressure in a predetermined time. The patient fixes the respiratory rate and the duration of inspiration, triggering all the cycles. Device model: Stellar 150® (ResMed, Australia).

Ventilator maintains a continuous positive airway pressure during the entire cycle. Device model: Stellar 150® (ResMed, Australia).

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hypercapnic chronic respiratory failure due to restrictive pulmonary disease (with usual criteria for home NonInvasive Mechanical Ventilation).
  • Transcutaneous carbon dioxide (CO2) basal pressure ≥ 50 mmHg when conscious.
  • Clinically stable (within the previous month).
  • Patients without previous NonInvasive Mechanical Ventilation treatment.

You may not qualify if:

  • Clinical exacerbation.
  • Chronic airflow limitation Forced expiratory volume in 1 second/Forced vital capacity (FEV1/FVC) ratio \< 70% or Sleep Apnea-Hypopnea Syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Barcelona, 08025, Spain

Location

MeSH Terms

Conditions

Neuromuscular DiseasesObesity Hypoventilation Syndrome

Condition Hierarchy (Ancestors)

Nervous System DiseasesSleep Apnea, ObstructiveSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesHypoventilationRespiratory InsufficiencySleep Disorders, IntrinsicDyssomniasSleep Wake DisordersObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Pedro A Anton Albisu, Medical Dr

    Fundacio Gestio Sanitaria de l'Hospital de la Santa Creu i Sant Pau

    PRINCIPAL INVESTIGATOR
  • Patricia Peñacoba Toribio, Physician

    Fundacio Gestio Sanitaria de l'Hospital de la Santa Creu i Sant Pau

    STUDY CHAIR
  • Macarena Segura, Physiotherapist

    Fundacio Gestio Sanitaria de l'Hospital de la Santa Creu i Sant Pau

    STUDY CHAIR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2013

First Posted

November 25, 2013

Primary Completion

December 1, 2016

Last Updated

March 21, 2024

Record last verified: 2015-10

Locations